Extensive in vitro and in vivo tests have been performed for a scientific study on the degradation of vascular scaffolds (bioresorbable stents) made from the RESOLOY® magnesium alloy.
The results confirm that the degradation time of RESOLOY® can be adjusted thanks to a double coating of fluoride and polymers. A significantly slower degradation is achieved in vitro compared to the Magmaris®.
An additional advantage is that RESOLOY® degrades with no residue. The animal tests confirm the in vitro results from the test laboratory and demonstrate that RESOLOY® is highly biocompatible. The results of the published study demonstrate the high degree of safety and efficacy of the alloy.
The study was published here on January 1, 2021 by the scientific publisher John Wiley & Sons.
After more than 15 years of development, the unique RESOLOY® alloy is ready for implants. MeKo manufactures scaffolds and other implants, which completely dissolve in the body when the healing is done. The first customer products are in the test phase.